Anuja Kriplani

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial”.

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

The 30 ROC trial: Precision intra-treatment imaging guiding major radiation reduction in human papillomavirus related oropharyngeal cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6019

N/A

0.406DataRank · unranked

14 citations

Eric J. Sherman, Heiko Schöder, Sean M. McBride, Yao Yu, Jung Julie Kang +15 more

Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations

Cancer Medicine(2023)10.1002/cam4.5598

N/A

0.360DataRank · unranked

10 citations

Susan Chimonas, Sham Mailankody, Michelle Kim, Nicholas Silva, Anuja Kriplani +9 more

Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6587

N/A

0.241DataRank · unranked

4 citations

Eric J. Sherman, Anuja Kriplani, Loren S. Michel, Lara Dunn, James Fetten +14 more

Role of primary care in opioid prescribing for older head and neck cancer survivors

Cancer(2024)10.1002/cncr.35478

N/A

0DataRank · unranked

1 citations

Akriti Mishra Meza, Patrick T. Bradshaw, Sankeerth Jinna, Natalie Moryl, Anuja Kriplani +5 more

A phase II study of lenvatinib plus pembrolizumab in patients with recurrent/metastatic salivary gland cancers.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.6103

N/A

0DataRank · unranked

0 citations

Eric J. Sherman, Anuja Kriplani, James Fetten, Loren S. Michel, Michael Hwang +6 more

A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Oral Oncology(2025)10.1016/j.oraloncology.2025.107524

N/A

0DataRank · unranked

0 citations

Alan L. Ho, Loren S. Michel, Winston Wong, Juliana Eng, Iris Zhi +9 more

The Head and Neck Survivorship Tool (HN-STAR) Trial (WF-1805CD): A protocol for a cluster-randomized, hybrid effectiveness-implementation, pragmatic trial to improve the follow-up care of head and neck cancer survivors

Contemporary Clinical Trials(2021)10.1016/j.cct.2021.106448

N/A

0DataRank · unranked

14 citations

Jamie S. Ostroff, Chandylen L. Nightingale, Thomas M. Atkinson, Eleanor C. Davidson, Sankeerth Jinna +9 more

Experiences with pain management for survivors of complex cancers: Focus on opioids and cannabis.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12118

N/A

0DataRank · unranked

0 citations

Susan Chimonas, Sankeerth Jinna, Jessica Brens, Anuja Kriplani, Andrew Salner +5 more

A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer

Oral Oncology(2024)10.1016/j.oraloncology.2024.106861

N/A

0DataRank · unranked

8 citations

David G. Pfister, Sarah Stein, Winston Wong, Eric J. Sherman, James Fetten +6 more